A purple and pink letter v on a white background.
January 16, 2019

The Benefits of Dermal Rejuvenation for Optimal Treatment Efficacy

Pre- and post-treatment patient support is ideal for boosting the effects of any long-term aesthetics treatment plan, not to mention it’s an essential consideration for patients when it comes to rating their overall satisfaction with a particular treatment provider. As a treatment provider who cares about building a brand through positive online reviews and effective word of mouth, delivering on your promise of optimal results is key to the process. While ensuring your patients have a point of contact for any questions that pop up throughout their treatment plan and recommending an at-home skin care regimen are both ideal, there is another way to boost patient satisfaction and not only achieve, but also maintain optimal results for facial aesthetic treatment patients: dermal rejuvenation.

What Is Dermal Rejuvenation?

Dermal rejuvenation treatments offer patients a relaxing treatment experience backed by advanced technology, and may be offered by itself or as part of a more comprehensive facial aesthetic treatments package, making it an ideal treatment for nearly all types of patients. Dermal rejuvenation treatments work to deep-clean pores, which in turn brighten dull skin, improve uneven skin tone, boost skin elasticity, remove skin impurities like blackheads and whiteheads, control sebum secretion, moisturize the skin, and enhance the effectiveness of post-treatment skin care products or complementary facial and aesthetic therapies.

Dermal rejuvenation devices, like the Venus Glow™, feature a lightweight applicator that utilizes a tri-modality dermal system consisting of a vacuum, 360-degree rotating tip, and two jet streams of saline that each measure just 50-70 microns wide. Smaller than the average pore size, this enables the saline to efficiently and effectively deep-clean each pore, while the vacuum gently pulls the skin into the top of the applicator to open up pores, remove impurities, and increase local micro-blood circulation. At the same time, the tip is also spinning 360 degrees to evenly spread the saline and micro-massage the skin, which increases the spread of nutrients released into the bloodstream. The end result is skin that instantly looks and feels healthier, cleaner, and more rejuvenated after each treatment.

How to Incorporate Dermal Rejuvenation Treatments into Your Practice

With the global cosmetic products market expected to grow 7.14% by 2023 with a $805.61 billion value, and the skin care market alone expected to reach $180.3 billion by 2024, it’s clear that consumers are willing to spend money when it comes to their skin—especially on skin care that works and offers immediate, visible results. Venus Glow™ is a dermal rejuvenation solution that will enable you as a provider to offer patients the immediate results they’re looking for, while also growing your bottom line with expanded treatment options, making it the most cost-effective dermal rejuvenation solution.

This gentle, non-invasive treatment is an especially effective solution for younger cosmetic patients seeking an early start to healthier skin and a regular anti-aging routine to sustain skin health. Treatments can be customized to each patient’s needs with three tip rotation speeds and three levels of suction to choose from. Paired with advanced post-treatment skin care products or as part of a long-term aesthetics treatment plan, Venus Glow™ dermal rejuvenation treatments could offer that little extra boost your before-and-after pictures need to help draw in more patients and have your clinic’s calendar fully booked. Plus, with a low consumables cost and Venus Concept’s unique business model, which ensures low-risk, higher-return ownership, Venus Glow™ is a very affordable aesthetics machine to own and maintain.

To learn more about the benefits of dermal rejuvenation, Venus Glow™, and Venus Concept’s industry-first and only true subscription model, contact an expert today.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.